tirzepatide pure 10mg — Dual Receptor Agonist (GLP-1/GIP) — Research Peptide Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

BLACK BOX WARNING: Risk of Thyroid C-Cell Tumors In animal studies, semaglutide caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)

Results vary by individual and treatment type

UK-based dispatch: Sourcing from a UK-based peptide distributor minimises transit time and cold chain risk during shipping

its not just for athletes or celebrities

The clinical research and emerging data on tirzepatide-based compounds, including GLP-1 GIP B12 formulations, point to a range of metabolic, cardiovascular, and anti-inflammatory benefits that extend well beyond the number on the scale

Change (rotate) your injection site with each injection